A citation-based method for searching scientific literature

A J Infante, H A Britton, T DeNapoli, L A Middelton, M J Lenardo, C E Jackson, J Wang, T Fleisher, S E Straus, J M Puck. J Pediatr 1998
Times Cited: 87







List of co-cited articles
466 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
G H Fisher, F J Rosenberg, S E Straus, J K Dale, L A Middleton, A Y Lin, W Strober, M J Lenardo, J M Puck. Cell 1995
81

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
F Rieux-Laucat, F Le Deist, C Hivroz, I A Roberts, K M Debatin, A Fischer, J P de Villartay. Science 1995
72

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
M C Sneller, J Wang, J K Dale, W Strober, L A Middelton, Y Choi, T A Fleisher, M S Lim, E S Jaffe, J M Puck,[...]. Blood 1997
269
57


Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
C E Jackson, R E Fischer, A P Hsu, S M Anderson, Y Choi, J Wang, J K Dale, T A Fleisher, L A Middelton, M C Sneller,[...]. Am J Hum Genet 1999
162
52

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
M C Sneller, S E Straus, E S Jaffe, J S Jaffe, T A Fleisher, M Stetler-Stevenson, W Strober. J Clin Invest 1992
231
51

Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.
A Bettinardi, D Brugnoni, E Quiròs-Roldan, A Malagoli, S La Grutta, A Correra, L D Notarangelo. Blood 1997
157
45

Pathological findings in human autoimmune lymphoproliferative syndrome.
M S Lim, S E Straus, J K Dale, T A Fleisher, M Stetler-Stevenson, W Strober, M C Sneller, J M Puck, M J Lenardo, K S Elenitoba-Johnson,[...]. Am J Pathol 1998
145
43

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
R Watanabe-Fukunaga, C I Brannan, N G Copeland, N A Jenkins, S Nagata. Nature 1992
37

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
J Wu, J Wilson, J He, L Xiang, P H Schur, J D Mountz. J Clin Invest 1996
347
37

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
J Wang, L Zheng, A Lobito, F K Chan, J Dale, M Sneller, X Yao, J M Puck, S E Straus, M J Lenardo. Cell 1999
464
37

Clinical, immunological, and pathological consequences of Fas-deficient conditions.
F Le Deist, J F Emile, F Rieux-Laucat, M Benkerrou, I Roberts, N Brousse, A Fischer. Lancet 1996
151
35

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
S E Straus, E S Jaffe, J M Puck, J K Dale, K B Elkon, A Rösen-Wolff, A M Peters, M C Sneller, C W Hallahan, J Wang,[...]. Blood 2001
304
35

Chronic lymphadenopathy simulating malignant lymphoma.
V C Canale, C H Smith. J Pediatr 1967
145
33

Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.
U Dianzani, M Bragardo, D DiFranco, C Alliaudi, P Scagni, D Buonfiglio, V Redoglia, S Bonissoni, A Correra, I Dianzani,[...]. Blood 1997
129
29

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
F Rieux-Laucat, S Blachère, S Danielan, J P De Villartay, M Oleastro, E Solary, B Bader-Meunier, P Arkwright, C Pondaré, F Bernaudin,[...]. Blood 1999
116
29


An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
S E Straus, M Sneller, M J Lenardo, J M Puck, W Strober. Ann Intern Med 1999
230
26

The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations.
A K Vaishnaw, J R Orlinick, J L Chu, P H Krammer, M V Chao, K B Elkon. J Clin Invest 1999
124
26

Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder.
Y Kasahara, T Wada, Y Niida, A Yachie, H Seki, Y Ishida, T Sakai, F Koizumi, S Koizumi, T Miyawaki,[...]. Int Immunol 1998
71
30

Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
D A Martin, L Zheng, R M Siegel, B Huang, G H Fisher, J Wang, C E Jackson, J M Puck, J Dale, S E Straus,[...]. Proc Natl Acad Sci U S A 1999
145
25

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
T Takahashi, M Tanaka, C I Brannan, N A Jenkins, N G Copeland, T Suda, S Nagata. Cell 1994
24

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Hyung J Chun, Lixin Zheng, Manzoor Ahmad, Jin Wang, Christina K Speirs, Richard M Siegel, Janet K Dale, Jennifer Puck, Joie Davis, Craig G Hall,[...]. Nature 2002
495
22

Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis.
L Pensati, A Costanzo, A Ianni, D Accapezzato, R Iorio, G Natoli, R Nisini, C Almerighi, C Balsano, P Vajro,[...]. Gastroenterology 1997
53
30

Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation.
B J Sleight, V S Prasad, C DeLaat, P Steele, E Ballard, R J Arceci, C L Sidman. Bone Marrow Transplant 1998
38
42


Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.
R M Siegel, J K Frederiksen, D A Zacharias, F K Chan, M Johnson, D Lynch, R Y Tsien, M J Lenardo. Science 2000
497
18

Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
J J Bleesing, M R Brown, S E Straus, J K Dale, R M Siegel, M Johnson, M J Lenardo, J M Puck, T A Fleisher. Blood 2001
93
18

Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression.
U Lopatin, X Yao, R K Williams, J J Bleesing, J K Dale, D Wong, J Teruya-Feldstein, S Fritz, M R Morrow, I Fuss,[...]. Blood 2001
74
20

Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.
K Grønbaek, P T Straten, E Ralfkiaer, V Ahrenkiel, M K Andersen, N E Hansen, J Zeuthen, K Hou-Jensen, P Guldberg. Blood 1998
250
16

Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation.
M Benkerrou, F Le Deist, J P de Villartay, S Caillat-Zucman, F Rieux-Laucat, N Jabado, M Cavazzana-Calvo, A Fischer. Eur J Immunol 1997
32
43

Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
M van der Burg, R de Groot, W M Comans-Bitter, J C den Hollander, H Hooijkaas, H J Neijens, R M Berger, A P Oranje, A W Langerak, J J van Dongen. Pediatr Res 2000
41
31

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer,[...]. N Engl J Med 2004
192
14

Mutations in the Fas antigen in patients with multiple myeloma.
T H Landowski, N Qu, I Buyuksal, J S Painter, W S Dalton. Blood 1997
191
13

The Fas death factor.
S Nagata, P Golstein. Science 1995
13


Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.
F C Kischkel, S Hellbardt, I Behrmann, M Germer, M Pawlita, P H Krammer, M E Peter. EMBO J 1995
13

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.
N Itoh, S Yonehara, A Ishii, M Yonehara, S Mizushima, M Sameshima, A Hase, Y Seto, S Nagata. Cell 1991
13

CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia.
C Beltinger, E Kurz, T Böhler, M Schrappe, W D Ludwig, K M Debatin. Blood 1998
111
12

Monoclonal antibody-mediated tumor regression by induction of apoptosis.
B C Trauth, C Klas, A M Peters, S Matzku, P Möller, W Falk, K M Debatin, P H Krammer. Science 1989
12


Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.
M Lenardo, K M Chan, F Hornung, H McFarland, R Siegel, J Wang, L Zheng. Annu Rev Immunol 1999
781
12

NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain.
B Huang, M Eberstadt, E T Olejniczak, R P Meadows, S W Fesik. Nature 1996
304
11

Structure of the human APO-1 gene.
I Behrmann, H Walczak, P H Krammer. Eur J Immunol 1994
149
11


FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.
M Muzio, A M Chinnaiyan, F C Kischkel, K O'Rourke, A Shevchenko, J Ni, C Scaffidi, J D Bretz, M Zhang, R Gentz,[...]. Cell 1996
11

Autoimmune lymphoproliferative syndrome, a disorder of apoptosis.
C E Jackson, J M Puck. Curr Opin Pediatr 1999
59
16

Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.
J J Bleesing, S E Straus, T A Fleisher. Pediatr Clin North Am 2000
61
16

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
Joao B Oliveira, Jack J Bleesing, Umberto Dianzani, Thomas A Fleisher, Elaine S Jaffe, Michael J Lenardo, Frederic Rieux-Laucat, Richard M Siegel, Helen C Su, David T Teachey,[...]. Blood 2010
254
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.